Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. New Morningstar Analyst Report for Mallinckrodt PLC

    Stock Reports

    Wed, 9 Apr 2014

    Covidien, he was CEO of Bayer Healthcare 's U.S. Pharmaceutical ..... s global specialty pharmaceuticals business. Given Mallinckrodt ..... experience at a firm like Bayer , which also has a ..... segments: generic pharmaceuticals , branded pharmaceuticals

  2. BRIEF- Bayer initiates two phase III trials with rivaroxaban in medically-ill patients and children at high risk of blood clots

    Headlines

    Mon, 31 Mar 2014

    FRANKFURT, March 31 (Reuters) - Bayer AG : * Says initiates two phase III trials with Rivaroxaban in medically-ill

  3. BRIEF- Bayer sells patents for carbon nanotubes and graphenes

    Headlines

    Mon, 31 Mar 2014

    FRANKFURT, March 31 (Reuters) - Bayer AG : * Says sells patents for carbon nanotubes and graphenes

  4. BRIEF- Bayer expands production for coating raw materials in China

    Headlines

    Mon, 24 Mar 2014

    FRANKFURT, March 24 (Reuters) - Bayer AG : * Bayer says expands production for coating raw materials in China * Says with an annual capacity of 50,000 metric tons, it will be the one of

  5. BRIEF- Bayer starts new Phase IIIb study with lung drug Riociguat

    Headlines

    Thu, 13 Mar 2014

    FRANKFURT, March 13 (Reuters) - Bayer AG : * Says starts phase iiib study with riociguat in pah patients who had

  6. Bayer eyes 8 pct annual pharma sales growth through 2016

    Headlines

    Wed, 12 Mar 2014

    FRANKFURT, March 12 (Reuters) - German drugmaker Bayer said on Wednesday it aims to increase its pharmaceuticals sales by 8 percent annually on average until 2016, adjusted for currency and portfolio effects, on the back of newly launched drugs.

  7. BRIEF- Bayer says to invest more than 500 million euros for the manufacturing of hemophilia a products currently in development

    Headlines

    Tue, 11 Mar 2014

    FRANKFURT, March 11 (Reuters) - Bayer AG says: * to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development Expansion of manufacturing capacities for innovative therapy options

  8. Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals

    Headlines

    Fri, 7 Mar 2014

    Reed : Introduction Spectrum Pharmaceuticals ( SPPI ) is a company with over ..... Pfizer/Takeda for Fusilev, Bayer for Zevalin, Topotarget for ..... perceived prospects of Spectrum Pharmaceuticals have not been bright. Spectrum

  9. BRIEF- Bayer Cropscience acquires Biagro Group

    Headlines

    Thu, 6 Mar 2014

    FRANKFURT, March 6 (Reuters) - Bayer AG says: * Bayer CropScience to strengthen global seedgrowth business with acquisition of Biagro Group * Established in 1984, Biagro has approximately 140 employees and production facilities in Argentina and Brazil.

  10. BRIEF- Bayer says holds 98.2 pct of Algeta shares, completes offer

    Headlines

    Thu, 6 Mar 2014

    FRANKFURT, March 6 (Reuters) - Bayer AG : * Says completes takeover offer of Algeta * Says holds 98.2 percent of Algeta shares

« Prev12345Next »
Content Partners